Endogenous sphingosine-1-phosphate as a radioprotector of intestinal tissues

内源性 1-磷酸鞘氨醇作为肠道组织的辐射保护剂

基本信息

  • 批准号:
    7472942
  • 负责人:
  • 金额:
    $ 49.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ceramide and sphingosine-1-phosphate (S1P) are bioactive lipids that regulate cell survival through activation of specific signaling pathways. Ceramide accumulates in cells in response to radiation and activates apoptosis pathways. Inhibiting ceramide synthesis protects against radiation injury. In contrast, the ceramide metabolite S1 P promotes cell survival in response to stress and is essential for angiogenesis. S1 P antagonizes apoptotic pathways including those induced by ceramide and radiation. Importantly, S1P prevents radiation-induced apoptosis and sterility in mice. Thus, while ceramide contributes to radiation enteritis, its conversion to S1P provides an internal fine-tuning signal that limits the intensity of radiation responses. Our preliminary studies indicate that S1P is a potent radioprotectant of the gut, promoting cell, tissue and animal survival after lethal doses of radiation. However, S1P is difficult to deliver. Thus, we have devised an alternative approach to raise intracellular levels of S1P and achieve radioprotection. S1P is catabolized by the enzyme S1 P lyase (SPL). SPL is highly expressed in intestinal villi and colonic crypts, where it maintains low S1 P levels, promoting cell turnover. SPL expression is induced by DNA damage and radiation in vitro and in vivo, and SPL expression promotes radiation-induced apoptosis, whereas SPL inhibition attenuates apoptosis after DNA damage. Tetrahydroxybutyl-imidazole (THI), a small molecule constituent of caramel food coloring, was recently found to be an SPL inhibitor. We show that oral administration of THI to mice reduces SPL activity and elevates S1P levels in colonic and intestinal tissues. Based on these findings and the observed radioprotective effect of S1 P in mice, we hypothesize that THI provides a safe means of achieving radioprotection in the gut and other tissues by rapidly inhibiting SPL activity and elevating intracellular and circulating levels of the endogenous radioprotectant, S1 P. To address this possibility, we have proposed three integrated specific aims: 1) To define the kinetics and dose requirements needed for THI to raise tissue and circulating S1 P levels; 2) To evaluate the pre- and post-expo-sure efficacy of THI as a protector of radiation-induced intestinal pathology; 3) To assess whether THI administration can prolong survival after radiation exposure. THI is an ideal candidate radioprotective agent due to its ease of delivery, minimal associated toxicity profile, and potential for rapid product development and multi-organ radioprotection.
描述(由申请人提供):神经酰胺和鞘氨醇-1-磷酸(S1P)是通过激活特定信号通路调节细胞存活的生物活性脂质。神经酰胺在细胞中积聚以响应辐射并激活凋亡途径。抑制神经酰胺的合成可以防止辐射损伤。相比之下,神经酰胺代谢物SlP响应于应激促进细胞存活,并且对于血管生成是必需的。S1P拮抗包括由神经酰胺和辐射诱导的凋亡途径。重要的是,S1P可防止小鼠辐射诱导的细胞凋亡和不育。因此,虽然神经酰胺有助于放射性肠炎,但其转化为S1P提供了一个内部微调信号,限制了辐射反应的强度。我们的初步研究表明,S1P是一种有效的肠道辐射防护剂,在致死剂量的辐射后促进细胞、组织和动物的存活。然而,S1P很难实现。因此,我们设计了一种替代方法来提高细胞内S1P水平并实现辐射防护。S1P被酶S1P裂解酶(SPL)分解代谢。SPL在肠绒毛和结肠隐窝中高度表达,在那里它维持低SlP水平,促进细胞更新。SPL的表达是由DNA损伤和辐射在体外和体内诱导的,SPL的表达促进辐射诱导的细胞凋亡,而SPL抑制减弱DNA损伤后的细胞凋亡。四羟基丁基咪唑(THI)是焦糖色素中的一种小分子成分,最近被发现是SPL抑制剂。我们表明,口服THI小鼠降低SPL活性,提高结肠和肠组织中的S1P水平。基于这些发现和在小鼠中观察到的S1P的辐射防护作用,我们假设THI通过快速抑制SPL活性和升高内源性辐射防护剂S1P的细胞内和循环水平,提供了在肠道和其他组织中实现辐射防护的安全手段。为了解决这种可能性,我们提出了三个综合的具体目标:1)确定THI提高组织和循环S1P水平所需的动力学和剂量要求; 2)评估THI作为辐射诱导的肠道病理学的保护剂的暴露前和暴露后的功效; 3)评估THI施用是否可以延长辐射暴露后的存活。THI是一种理想的候选辐射防护剂,因为它易于递送,最小的相关毒性,以及快速产品开发和多器官辐射防护的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JULIE D SABA其他文献

JULIE D SABA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JULIE D SABA', 18)}}的其他基金

Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
  • 批准号:
    10515118
  • 财政年份:
    2022
  • 资助金额:
    $ 49.24万
  • 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
  • 批准号:
    10705139
  • 财政年份:
    2022
  • 资助金额:
    $ 49.24万
  • 项目类别:
Endogenous and Dietary Sphingolipids as Modulators in Inflammatory Bowel Disease
内源性和膳食鞘脂作为炎症性肠病的调节剂
  • 批准号:
    10222659
  • 财政年份:
    2018
  • 资助金额:
    $ 49.24万
  • 项目类别:
S1P lyase in colon cancer
结肠癌中的 S1P 裂解酶
  • 批准号:
    8806359
  • 财政年份:
    2014
  • 资助金额:
    $ 49.24万
  • 项目类别:
Agilent 6490 Triple Quadrupole Mass Spectrometer
Agilent 6490 三重四极杆质谱仪
  • 批准号:
    8640509
  • 财政年份:
    2014
  • 资助金额:
    $ 49.24万
  • 项目类别:
IVIS Spectrum small animal imaging system
IVIS Spectrum 小动物成像系统
  • 批准号:
    8447251
  • 财政年份:
    2013
  • 资助金额:
    $ 49.24万
  • 项目类别:
FASEB SRC on Lysophospholipd Mediators in Health and Disease
FASEB SRC 关于健康和疾病中的溶血磷脂介质
  • 批准号:
    8203973
  • 财政年份:
    2011
  • 资助金额:
    $ 49.24万
  • 项目类别:
Endogenous sphingosine-1-phosphate as a radioprotector of intestinal tissues
内源性 1-磷酸鞘氨醇作为肠道组织的辐射保护剂
  • 批准号:
    8010757
  • 财政年份:
    2010
  • 资助金额:
    $ 49.24万
  • 项目类别:
Soy sphingadienes and related compounds in colon cancer chemoprevention and treat
大豆鞘氨醇及相关化合物在结肠癌的化学预防和治疗中的作用
  • 批准号:
    7916337
  • 财政年份:
    2009
  • 资助金额:
    $ 49.24万
  • 项目类别:
Soy sphingadienes and related compounds in colon cancer chemoprevention and treat
大豆鞘氨醇及相关化合物在结肠癌的化学预防和治疗中的作用
  • 批准号:
    7713515
  • 财政年份:
    2009
  • 资助金额:
    $ 49.24万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 49.24万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 49.24万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 49.24万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 49.24万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 49.24万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 49.24万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 49.24万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 49.24万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 49.24万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 49.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了